Revenue by Geography

Financials in millions GBP. Fiscal year is October - September.

Millions GBP. Fiscal year is Oct - Sep.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015	FY 2014	FY 2013	FY 2012
Period Ending	Sep '25 Sep 30, 2025	Sep '24 Sep 30, 2024	Sep '23 Sep 30, 2023	Sep '22 Sep 30, 2022	Sep '21 Sep 30, 2021	Sep '20 Sep 30, 2020	Sep '19 Sep 30, 2019	Sep '18 Sep 30, 2018	Sep '17 Sep 30, 2017	Sep '16 Sep 30, 2016	Sep '15 Sep 30, 2015	Sep '14 Sep 30, 2014	Sep '13 Sep 30, 2013	Sep '12 Sep 30, 2012
United Kingdom Revenue	279.80M	273.00M
United Kingdom Revenue Growth	2.49%	2.21%
Rest of Europe Revenue	247.50M	267.80M
Rest of Europe Revenue Growth	-7.58%	27.34%
USA Revenue	802.60M	626.10M
USA Revenue Growth	28.19%	16.46%
Rest of World Revenue	194.60M	196.50M
Rest of World Revenue Growth	-0.97%	6.04%
Revenue (Total)	1.52B	1.36B
Revenue (Total) Growth	11.82%	13.59%

Revenue

Financials in millions GBP. Fiscal year is October - September.

Millions GBP. Fiscal year is Oct - Sep.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015	FY 2014	FY 2013	FY 2012
Period Ending	Sep '25 Sep 30, 2025	Sep '24 Sep 30, 2024	Sep '23 Sep 30, 2023	Sep '22 Sep 30, 2022	Sep '21 Sep 30, 2021	Sep '20 Sep 30, 2020	Sep '19 Sep 30, 2019	Sep '18 Sep 30, 2018	Sep '17 Sep 30, 2017	Sep '16 Sep 30, 2016	Sep '15 Sep 30, 2015	Sep '14 Sep 30, 2014	Sep '13 Sep 30, 2013	Sep '12 Sep 30, 2012
Controls Revenue	833.50M	652.40M
Controls Revenue Growth	27.76%	14.78%
Seals Revenue	454.30M	489.10M
Seals Revenue Growth	-7.12%	16.73%
Life Sciences Revenue	225.80M	221.90M
Life Sciences Revenue Growth	1.76%	4.23%
Revenue (Other)	10.90M	-
Revenue (Total)	1.52B	1.36B
Revenue (Total) Growth	11.82%	13.59%

Financials in millions GBP. Fiscal year is October - September.

Millions GBP. Fiscal year is Oct - Sep.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015	FY 2014	FY 2013	FY 2012
Period Ending	Sep '25 Sep 30, 2025	Sep '24 Sep 30, 2024	Sep '23 Sep 30, 2023	Sep '22 Sep 30, 2022	Sep '21 Sep 30, 2021	Sep '20 Sep 30, 2020	Sep '19 Sep 30, 2019	Sep '18 Sep 30, 2018	Sep '17 Sep 30, 2017	Sep '16 Sep 30, 2016	Sep '15 Sep 30, 2015	Sep '14 Sep 30, 2014	Sep '13 Sep 30, 2013	Sep '12 Sep 30, 2012
United Kingdom Adjusted Operating Profit	8.60M	23.30M
United Kingdom Adjusted Operating Profit Growth	-63.09%	-19.10%
Rest of Europe Adjusted Operating Profit	48.30M	53.90M
Rest of Europe Adjusted Operating Profit Growth	-10.39%	56.23%
USA Adjusted Operating Profit	248.50M	165.50M
USA Adjusted Operating Profit Growth	50.15%	25.19%
Rest of World Adjusted Operating Profit	37.30M	42.30M
Rest of World Adjusted Operating Profit Growth	-11.82%	1.93%
Operating Income (Other)	-59.00M	-77.60M
Operating Income (Total)	283.70M	207.40M
Operating Income (Total) Growth	36.79%	13.15%

Financials in millions GBP. Fiscal year is October - September.

Millions GBP. Fiscal year is Oct - Sep.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015	FY 2014	FY 2013	FY 2012
Period Ending	Sep '25 Sep 30, 2025	Sep '24 Sep 30, 2024	Sep '23 Sep 30, 2023	Sep '22 Sep 30, 2022	Sep '21 Sep 30, 2021	Sep '20 Sep 30, 2020	Sep '19 Sep 30, 2019	Sep '18 Sep 30, 2018	Sep '17 Sep 30, 2017	Sep '16 Sep 30, 2016	Sep '15 Sep 30, 2015	Sep '14 Sep 30, 2014	Sep '13 Sep 30, 2013	Sep '12 Sep 30, 2012
Controls Adjusted Operating Profit	250.50M	169.90M
Controls Adjusted Operating Profit Growth	47.44%	24.38%
Seals Adjusted Operating Profit	87.80M	90.70M
Seals Adjusted Operating Profit Growth	-3.20%	14.81%
Life Sciences Adjusted Operating Profit	44.00M	46.80M
Life Sciences Adjusted Operating Profit Growth	-5.98%	8.33%
Corporate Adjusted Operating Profit	-41.30M	-22.40M
Operating Income (Other)	-57.30M	-77.60M
Operating Income (Total)	283.70M	207.40M
Operating Income (Total) Growth	36.79%	13.15%

Financials in millions GBP. Fiscal year is October - September.

Millions GBP. Fiscal year is Oct - Sep.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015	FY 2014	FY 2013	FY 2012
Period Ending	Sep '25 Sep 30, 2025	Sep '24 Sep 30, 2024	Sep '23 Sep 30, 2023	Sep '22 Sep 30, 2022	Sep '21 Sep 30, 2021	Sep '20 Sep 30, 2020	Sep '19 Sep 30, 2019	Sep '18 Sep 30, 2018	Sep '17 Sep 30, 2017	Sep '16 Sep 30, 2016	Sep '15 Sep 30, 2015	Sep '14 Sep 30, 2014	Sep '13 Sep 30, 2013	Sep '12 Sep 30, 2012
Controls Operating Profit	211.20M	132.30M
Controls Operating Profit Growth	59.64%	17.18%
Seals Operating Profit	79.00M	62.20M
Seals Operating Profit Growth	27.01%	11.47%
Life Sciences Operating Profit	34.80M	35.30M
Life Sciences Operating Profit Growth	-1.42%	-3.02%
Corporate Operating Profit	-41.30M	-22.40M
Operating Income (Total)	283.70M	207.40M
Operating Income (Total) Growth	36.79%	13.15%

Financials in millions GBP. Fiscal year is October - September.

Millions GBP. Fiscal year is Oct - Sep.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015	FY 2014	FY 2013	FY 2012
Period Ending	Sep '25 Sep 30, 2025	Sep '24 Sep 30, 2024	Sep '23 Sep 30, 2023	Sep '22 Sep 30, 2022	Sep '21 Sep 30, 2021	Sep '20 Sep 30, 2020	Sep '19 Sep 30, 2019	Sep '18 Sep 30, 2018	Sep '17 Sep 30, 2017	Sep '16 Sep 30, 2016	Sep '15 Sep 30, 2015	Sep '14 Sep 30, 2014	Sep '13 Sep 30, 2013	Sep '12 Sep 30, 2012
Life Sciences Organic Growth	6.00%	6.00%
Seals Organic Growth	2.00%	1.00%
Controls Organic Growth	20.00%	10.00%
Group Organic Growth	11.00%	6.00%

Updated Nov 18, 2025. Data Source: Fiscal.ai.